Exodus Point Capital Management, LP Roivant Sciences Ltd. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$10.36 - $11.74 $3.15 Million - $3.57 Million
304,207 New
304,207 $3.22 Million
Q3 2023

Nov 09, 2023
BUY
$9.76 - $13.19 $18,885 - $25,522
1,935 Added 5.8%
35,315 $412,000
Q2 2023

Aug 10, 2023
SELL
$7.09 - $10.08 $3.22 Million - $4.58 Million
-454,708 Reduced 93.16%
33,380 $336,000
Q1 2023

May 11, 2023
BUY
$6.92 - $9.98 $3.04 Million - $4.39 Million
439,783 Added 910.43%
488,088 $3.6 Million
Q4 2022

Feb 13, 2023
BUY
$3.36 - $7.99 $162,304 - $385,956
48,305 New
48,305 $386,000

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email